NCT04799249 Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Gemcitabine and Carboplatin for Metastatic Triple-Negative Breast Cancer (TNBC) Status COMPLETED Phase PHASE3
NCT04799080 Chemotherapy-induced Peripheral Neuropathy (CIPN) on Motor and Sensory Function Status COMPLETED Phase N/A
NCT04797728 Elacestrant in Preoperative Setting, a Window of Opportunity Study Status COMPLETED Phase EARLY_PHASE1
NCT04796363 US Guided Erector Spinae Plane Block in Breast Cancer Surgery: Analgesia, Spread and Immunomodulation Status COMPLETED Phase NA
NCT04795778 The Validity and Reliability of FIT-HaNSA in Breast Cancer Patients Status UNKNOWN Phase N/A
NCT04795349 New Techniques to evAlUate Response to neOadjuvant Treatments in bReast cAncer (AURORA) Status UNKNOWN Phase NA
NCT04792840 Skeletal Events of Hormonal Treatment and Radiotherapy in Patient With Breast Cacer Status UNKNOWN Phase N/A
NCT04792346 Ten Fraction Adjuvant Hypofractionated Radiotherapy in Node Positive Breast Cancer Status COMPLETED Phase N/A
NCT04791384 Phase Ib/II Trial of Abemaciclib and Elacestrant in Patients With Brain Metastasis Due to HR+/Her2- Breast Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT04781712 Feasibility of a Modular mHealth for Tailored Rehabilitation of Breast Cancer Status COMPLETED Phase NA
NCT04781062 Development of a Horizontal Data Integration Classifier for Noninvasive Early Diagnosis of Breast Cancer Status UNKNOWN Phase NA
NCT04780347 Albumin-bound Paclitaxel Combination With Capecitabine Versus Capecitabine Monotherapy in Paclitaxel/Docetaxel-resistant Advanced Breast Cancer Status UNKNOWN Phase PHASE2
NCT04779450 Effect of Telemonitoring on Functionality, Quality of Life and Risk of Lymphedema in Breast Cancer Survivors Status UNKNOWN Phase NA
NCT04778202 Diagnostic and Prognostic Value of MicroRNA in Breast Cancer Patients Status UNKNOWN Phase N/A
NCT04775043 Study Evaluating Hot Flashes in Hormone Sensitive Breast Cancer Status COMPLETED Phase N/A